Positron Emission Tomography/Magnetic Resonance Imaging in Patients
Stopped early · Not applicable
Conditions studied: Colon Cancer, Head and Neck Cancer, Lung Cancer, Lymphoma, Malignant Neoplasm, Melanoma, Unspecified Adult Solid Tumor, Protocol Specific, Unspecified Childhood Solid Tumor, Protocol Specific
In brief
This clinical trial studies positron emission tomography (PET)/magnetic resonance imaging (MRI) in patients undergoing PET/computed tomography (CT). Diagnostic procedures, such as PET/MRI, may help doctors diagnose cancer or help doctors predict a patient's response to treatment
Key facts
- Study ID
- NCT01557881
- Run by
- Case Comprehensive Cancer Center
- People needed
- 98
- Starts
- 2012-02-01
- Expected to finish
- 2015-04-01
- Last updated by the study team
- 2020-02-24
Who can join
Age: any. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Only patients who are referred by their physician to have a clinical PET/CT will be eligible to participate in the study
- we propose to obtain a second PET/MRI on 100 patients after their clinical PET/CT imaging that spans several disease categories and includes the following cancers: lung, colon, melanoma, head/neck and lymphoma
- In addition to oncology patients, we anticipate imaging a subset of non-cancer patients who will also be imaged subsequent to their clinical PET/CT who will be referrals from neurology and cardiology
- All subjects will be at least 18 years old, or if under 18, parents or guardians must give consent
- Subjects must be stable and have experienced no adverse events from previous clinical PET/CT examination
You may not qualify if…
- Subjects who do not meet the above inclusion criteria
- Subjects unwilling or unable to sign the informed consent form
- Subjects who are cognitively impaired and thus unable to give informed consent
- Subjects unable to undergo MRI scanning due to exclusion via University Hospital Case Medical Center (UHCMC) MRI restrictions (e.g. implanted metallic or electronic devices, hip or other joint replacements, history of kidney disease, unacceptable creatinine or glomerular filtration rate [GFR], etc)
- Patients who are pregnant
Where it is running
- University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.